LumiraDx (LMDX) Earnings
Price: $0.02
Market Cap: $5.10M
Market Cap: $5.10M
Revenue (TTM): $254.48M
Net Income: $-449.19M
Net Income: $-449.19M
P/E Ratio: -0.01
EPS (TTM): $-1.59
EPS (TTM): $-1.59
Earnings Dates
LumiraDx (LMDX) reports its earnings quarterly. Here are the key details:
Next Earnings Date
- Date:
- Time of Day:
- Estimated EPS: $N/A
Last Earnings Report
- Date: August 22, 2024
- EPS: $-
- EPS Estimate: $None
LumiraDx's next earnings report is scheduled for .
In its last earnings report on August 22, 2024, LumiraDx reported earnings per share (EPS) of $-, compared to an estimated EPS of $-. The company reported revenue of $-, compared to an estimated revenue of $-.
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q2 | 2023 | 2023-08-24 | $-0.15 | $-0.16 |
| Read Transcript | Q1 | 2023 | 2023-05-16 | $-0.15 | $-0.14 |
| Read Transcript | Q4 | 2022 | 2023-03-21 | $-0.19 | $-0.32 |
| Read Transcript | Q3 | 2022 | 2022-11-12 | N/A | N/A |
| Read Transcript | Q2 | 2022 | 2022-08-18 | $-0.26 | $-0.58 |
| Read Transcript | Q1 | 2022 | 2022-05-11 | $-0.06 | $-0.22 |
| Read Transcript | Q4 | 2021 | 2022-03-10 | $-0.07 | $-0.08 |
| Read Transcript | Q3 | 2021 | 2021-11-10 | $-0.21 | $-0.16 |
Earnings History
| Date | EPS | EPS Estimate | Revenue | Revenue Estimate |
|---|---|---|---|---|
| August 22, 2024 | $ | $ | $- | $- |
| May 14, 2024 | $ | $ | $- | $- |
| March 19, 2024 | $ | $-0.06 | $- | $19.80M |
| November 08, 2023 | $-0.47 | $-0.11 | $- | $20.05M |
| August 24, 2023 | $-0.16 | $-0.15 | $21.00M | $- |
| May 16, 2023 | $-0.14 | $-0.15 | $22.17M | $- |
| March 21, 2023 | $-0.32 | $-0.19 | $41.12M | $41.75M |
| November 09, 2022 | $-0.47 | $-0.30 | $42.22M | $- |
| August 18, 2022 | $-0.58 | $-0.26 | $44.73M | $- |
| May 11, 2022 | $-0.22 | $-0.06 | $126.41M | $113.13M |
| March 10, 2022 | $-0.08 | $-0.07 | $118.25M | $74.43M |
| November 10, 2021 | $-0.16 | $-0.21 | $109.08M | $- |
| August 02, 2021 | $-0.06 | $ | $87.22M | $- |
| May 25, 2021 | $-0.72 | $ | $106.87M | $- |
| January 27, 2021 | $-0.28 | $ | $112.28M | $- |
| September 30, 2020 | $-0.25 | $ | $13.93M | $- |
| June 29, 2020 | $-0.24 | $ | $34.79M | $- |
| March 30, 2020 | $-0.24 | $ | $34.79M | $- |
| December 30, 2019 | $-0.13 | $ | $5.79M | $- |
| September 29, 2019 | $-0.13 | $ | $5.79M | $- |
Annual Earnings
Annual Revenue
$254.48M
Fiscal Year 2022Annual Net Income
$-449.19M
Fiscal Year 2022Annual EPS
$-1.59
Fiscal Year 2022Quarterly Earnings
Revenue
$21.00M
Quarter Ending June 30, 2023Net Income
$-49.74M
Quarter Ending June 30, 2023EPS
$-0.16
Quarter Ending June 30, 2023Earnings Metrics
Earnings Yield
-176.84%
Year Ending December 31, 2022P/E Ratio
-0.57
Year Ending December 31, 2022Revenue Per Share
$0.90
Year Ending December 31, 2022Earnings Yield (TTM)
-9947.02%
Trailing Twelve MonthsP/E Ratio (TTM)
-0.01
Trailing Twelve MonthsRevenue Per Share (TTM)
$0.90
Trailing Twelve MonthsFrequently Asked Questions
LumiraDx's next earnings date is scheduled for . The earnings call is expected to take place .
In its last earnings report on August 22, 2024, LumiraDx reported earnings per share (EPS) of $, compared to an estimated EPS of $. The company reported revenue of $-, compared to an estimated revenue of $-.
LumiraDx's current Price-to-Earnings (P/E) ratio is -0.57. The trailing twelve months (TTM) P/E ratio is -0.01. The P/E ratio is a valuation metric that compares a company's current share price to its earnings per share (EPS). A higher P/E ratio suggests that investors are expecting higher earnings growth in the future compared to companies with a lower P/E ratio.
For the fiscal year ending December 31, 2022, LumiraDx reported total revenue of $254.48M and net income of $-449.19M. This represents a net profit margin of -1.7651762838.
LumiraDx's earnings yield is -176.84%. The earnings yield is the inverse of the P/E ratio and represents the percentage of each dollar invested in the stock that was earned by the company.
LumiraDx's return on equity (ROE) is 427.37%. ROE is a measure of financial performance calculated by dividing net income by shareholders' equity. It measures how effectively management is using a company's assets to create profits.
LumiraDx's gross profit margin is -13.87%. This indicates that for every dollar of revenue, the company retains $-0.14 as gross profit after accounting for the cost of goods sold.